Multiple Vitestro devices have already been pre-ordered and are scheduled to be deployed at several European hospitals starting at the end of this year to help ease workload and provide a more consistent, improved patient experience. Vitestro is also currently leading the A.D.O.P.T. trial, the world’s largest evaluation of autonomous blood drawing devices.
Organizations Involved
Sonder Capital, NYBC Ventures, Invest-NL, European Innovation Council Fund
Founders
Toon Overbeeke, Brian Joseph
Company Description
Vitestro transform patient care with autonomous blood drawing technology.
Market
Medical Devices
Location
Utrecht,
The Netherlands
Coinvestors
Sonder Capital, NYBC Ventures, Invest-NL, European Innovation Council Fund